AI in Hypertension Treatment Education: Comparing GPT and Traditional Methods
AIHT-EDU
Application of Artificial Intelligence in Hypertension Pharmacotherapy Education: A Comparative Study of the GPT System and Traditional Teaching Methods
1 other identifier
interventional
52
1 country
1
Brief Summary
Educational Trial: GPT-Based Training vs. Traditional Teaching for Hypertension Management The goal of this educational trial is to determine whether a Generative Pre-trained Transformer (GPT)-based training system is more effective than traditional teaching methods in helping medical students master hypertension management plans. It will also evaluate the educational effectiveness and engagement of the GPT-based system. The main questions it aims to answer are: Does the GPT-based training improve the ability of students to develop effective hypertension management plans compared to traditional methods? How do students perceive the use of the GPT system in their learning process? Researchers will compare the GPT-based training system to traditional teaching methods to see if the innovative AI approach enhances learning outcomes in medical education. Participants will: Engage with either the GPT-based system or traditional teaching materials. Visit the educational facility periodically for assessments and feedback sessions. Keep a diary of their learning experiences, noting any difficulties or advantages they observe in the training method they are assigned.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 20, 2024
CompletedFirst Submitted
Initial submission to the registry
December 27, 2024
CompletedFirst Posted
Study publicly available on registry
January 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 12, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2025
CompletedDecember 9, 2025
March 1, 2025
9 months
December 27, 2024
December 8, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
structured theoretical exam scores
Structured Theoretical Exam Scores - Immediate and One-Month Follow-Up: This outcome measures the effectiveness of teaching hypertension management. Students take a structured theoretical exam immediately after the training and again one month later to assess knowledge retention. The exam covers hypertension pathophysiology, risk factors, diagnostics, and treatments. Scores range from 0 to 100, with higher scores indicating better knowledge acquisition and retention.
From enrollment to the end of treatment at 4 weeks
Clinical Case Test Scores on Hypertension
Clinical Case Test Scores on Hypertension - Immediate and One-Month Follow-Up:This outcome measures how well students apply theoretical knowledge to practical clinical scenarios. Tests are administered immediately after training and one month later, involving clinical simulations where students diagnose hypertension and develop treatment plans. Scores range from 0 to 100, with higher scores indicating better clinical reasoning and application of knowledge.
From enrollment to the end of treatment at 4 weeks
Secondary Outcomes (4)
Mood Elevation Scale
From enrollment to the end of treatment at 4 weeks
Cognitive Load Index (CLI)
From enrollment to the end of treatment at 4 weeks
Teaching Satisfaction Assessment
From enrollment to the end of treatment at 4 weeks
Technology Acceptance Model
From enrollment to the end of treatment at 4 weeks
Study Arms (2)
GPT-based training
EXPERIMENTALGenerative Pre-trained Transformer (GPT)-based training system
traditional training
ACTIVE COMPARATORtraditional training method
Interventions
GPT-based training whether could improve the ability of students to develop effective hypertension management plans
Eligibility Criteria
You may qualify if:
- Graduate or regulatory trainee, currently rotating in cardiology and willing to participate in research.
- Age between 18-30 years old, gender not limited.
- No specialized training experience in hypertension diagnosis and treatment, only possessing basic medical theoretical knowledge.
- Able to accept a 4-week teaching intervention (2 hours of study per week).
- Sign the informed consent form and be aware of the research purpose and process.
You may not qualify if:
- Graduate students or trained interns who have received specialized training in hypertension medication treatment.
- Students unable to complete the full course of study (e.g., rotations shorter than four weeks or potential mid-course withdrawal).
- Unable to consistently participate in educational interventions (e.g., conflicts with study schedule).
- Have severe physical or mental health issues that may affect the learning process.
- Have language comprehension barriers or cognitive impairments, making it difficult to complete learning tasks.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- zhen wanglead
Study Sites (1)
678 Furong Road, Economic Development Zone, Hefei City, Anhui Province, China
Hefei, Anhui, 230601, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
xianrui luo
The Second Hospital of Anhui Medical University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- physician-in-charge
Study Record Dates
First Submitted
December 27, 2024
First Posted
January 15, 2025
Study Start
October 20, 2024
Primary Completion
July 12, 2025
Study Completion
July 30, 2025
Last Updated
December 9, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share